Skip to content

Research

Research Team Led by Dr. Jim Bailey Receives $5.2 Million to Study Effectiveness of Text Messaging and Health Coaching in Improving Outcomes for Vulnerable Populations

faculty image
Dr. Jim Bailey

Jim Bailey, MD, MPH, professor of Internal Medicine and Preventive Medicine in the College of Medicine and director of the Center for Health System Improvement at the University of Tennessee Health Sciences Center, has been approved for a $5.2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). The funds, which will be distributed over four years and four months, will be used to study the effectiveness of patient-driven resources to improve health care for African-Americans who have uncontrolled diabetes and live in underserved areas. Read Full Story

Professors Yao Sun and Lu Lu of UTHSC Receive $1.99 Million Grant for Cardiovascular Disease Research

 

Dr. Yao Sun sitting at her desk
Dr. Yao Sun

Yao Sun, MD, PhD, professor in the Division of Cardiovascular Diseases in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), in a multidisciplinary collaborative effort with Lu Lu, MD, professor in the Department of Genetics, Genomics and Informatics in the College of Medicine at UTHSC, has received a grant totaling $1.99 million to study modifier genes that control the severity of hypertrophic cardiomyopathy (HCM). With HCM the heart muscle enlarges causing the walls of the ventricles to thicken affecting blood flow.

While the severity of HCM is largely determined by modifier genes, it is poorly understood. “The identification of modifier genes is a crucial research goal in HCM,” said Dr. Sun. “This project is well-suited to successfully identify genes that control clinical expression of HCM. If successful, this research could aide in developing novel strategies for the prevention and treatment of HCM.”  Read Full Story


Samuel Dagogo-Jack, MD, Director of the UTHSC Division of Endocrinology, Receives $1.1 Million Grant to Continue Diabetes Prevention Study

Samuel Dagogo-Jack, MD, FRCP standing at a hospital counter
Dr. Samuel Dagogo-Jack

Samuel Dagogo-Jack, MD, FRCP, of the University of Tennessee Health Science Center (UTHSC) has played a major role in the fight against diabetes throughout his career. Dr. Dagogo-Jack, who directs the Division of Endocrinology, Diabetes and Metabolism in the College of Medicine at UTHSC, has received a $1.1 million grant to continue the Diabetes Prevention Program Outcomes Study (DPPOS).

The grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, is for $228,000 a year over five years.  Read Full Story

Assistant Professor Dong Wang of UTHSC Receives $308,000 Grant for Heart Attack Research

Dr. Dong Wang at his desk in front of a computer
Dr. Dong Wang

With the help of a $308,000 grant from the American Heart Association, Dr. Dong Wang and his research team will be able to further explore ways to improve the treatment of patients with heart attack and ischemic heart disease.

Dong Wang, PhD, MD, assistant professor in the Department of Medicine at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $308,000 from the American Heart Association. The award will be used to support a project titled, “The Corin-ANP Axis in Myocardial Infarction and Ischemic Cardiomyopathy.” The award will be distributed over a four-year period. Read Full Story


Gustavo Miranda-Carboni of UTHSC Receives $158,232 Grant for Breast Cancer Research

Dr. Miranda-Carbon in a lab setting holding a syringe
Dr. Gustav Miranda-Carbon

Dr. Gustavo Miranda-Carboni and his research team have been awarded a $158,232 grant by the NIH that will allow them to develop targeted therapeutics to treat or prevent lung metastasis for triple negative breast cancer patients. Read Full Story

UTHSC Professor Ivan Gerling Receives $1.5 Million Grant for Type 1 Diabetes Research

Dr. Ivan Gerling in a lab
Dr. Ivan Gerling

A newly funded NIH grant will allow Dr. Ivan Gerling and his research team to further their studies into the process of Type 1 Diabetes. Their findings could provide a number of new potential drug targets that could stop or reverse the abnormal molecular processes and prevent or cure the disease. Read Full Story

Last Published: Apr 25, 2017